GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
GlycoMimetics (GLYC) - Total debt
Total debt on the balance sheet as of September 2023 : $1.01 M
According to GlycoMimetics 's latest financial reports the company's total debt is $1.01 M. A company’s total debt is the sum of all current and non-current debts.
GlycoMimetics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.91 M | -52.16% |
| 2021-12-31 | $1.92 M | -31.88% |
| 2020-12-31 | $2.81 M | -22.2% |
| 2019-12-31 | $3.62 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 2,899,035.16% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 7,002,123.87% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 2,012,956.59% | 🇫🇷 France |
 Palatin Technologies PTN | $0.82 M | -18.82% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.30 B | 29,917.99% | 🇺🇸 USA |